We are international
Donate
TEXT SIZE   


Myeloma Minute
November 5, 2015
11.05.15
November 5, 2015
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: Can DDT exposure cause myeloma?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

 

Saturday, November 14, 2015
Regional Community Workshop

Washington D.C.

Thursday, November 19, 2015
Living Well with Myeloma

"Myeloma 101: Updates on Treatment & Pain Management"

 

Saturday, November 21, 2015
Regional Community Workshop

Chicago, Illinois

 

Friday, December 4, 2015
IMF Satellite Symposium

Orlando, Florida/Live Stream

 

    

x

The Bad and the Good About Food, Cancer, and Longevity

In his blog this week, IMF Chairman Dr. Brian Durie discusses the media frenzy surrounding The World Health Organization (WHO) study that proposed red and processed meats could be linked to cancer. The WHO and its linked research group, the International Agency for Research on Cancer (IARC) classified bacon and hot dogs as “human carcinogens (Group 1).” That designation means they are causing cancer in the same way that tobacco and asbestos are classified as cancer-causing agents. There is more to this story than just the headlines however, and Dr. Durie explains more about what this study means HERE.

x

IMF Scores Support in Takeda Oncology's '3 Points for Patients' Campaign with NBA's Boston Celtics



 

The IMF is thrilled to announce their partnership with Takeda Oncology and their new campaign “3 Points for Patients,” with the Boston Celtics, which launched today. Each time the 17-time champion Boston Celtics sinks a 3-point basket during the regular NBA season, Takeda Oncology will make a donation to the IMF. With the high-scoring Celtics’ track record, that could result in an additional $25,000 to support IMF’s myeloma research and patient education programs. Read the full story, HERE.

 

x

Upcoming Regional Community Workshops for Washington D.C. and Chicago



 

Regional Community Workshops are informative half-day meetings designed to provide much of the same myeloma information as a Patient & Family Seminar, but in a condensed form. Upcoming workshops will be held in the Washington D.C. and Chicago, Illinois areas. The Washington D.C. workshop will take place on Saturday, November 14 from 9:30 AM to 3:00 PM at the Westin City Center and will feature speakers Dr. David Vesole, Professor of Medicine, Georgetown University; Dr. Rafat Abonour, Professor of Medicine, Indiana University, and Ann McNeill, RN, MSN, APN-C, John Theurer Cancer Center. The Chicago area workshop will take place on Saturday, November 21 from 9:30 AM to 3:00 PM at the Westin North Shore and will also feature speaker Dr. Rafat Abonour, as well as Joseph Tariman, Phd, ANP-BC, De Paul University. Both events are free, but you must register to reserve your seat by clicking on the link of the workshop you’d like to attend.

x

Register Now for the Next Living Well with Myeloma Teleconference on November 19


 

Don’t miss the next teleconference in the Living Well with Myeloma series happening Thursday, November 19.  IMF Chairman Dr. Brian Durie will present “Myeloma 101:  Updates on Treatment & Pain Management” during this informative teleconference, and will shed light on the most up-to-date therapies for myeloma patients. The 60-minute teleconference begins at 4 pm PT/7 pm ET and is not to be missed! To register, please click HERE.

 x

Register for the IMF Advocacy Team's Webinar on Understanding Clinical Pathways


 

Please join the IMF Advocacy team on Wednesday, November 11 from 7:00 – 7:30 PM EST, for a special presentation on Clinical Pathways. Pathways are a mechanism used by insurers to make health care costs more predictable by prescribing a course of treatment in which the type and timing of specific therapies are pre-determined. The presentation will go over how pathways are developed, so that you can make more informed decisions about your care. It will also cover how to talk to your physician about how these pathways are structured within their practices and whether they have placed you on a particular pathway. To register, please click HERE. We hope to see you there! 

 


Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles